MAPT and Alzheimer disease: By using the predicted P-tau/Aβ42 ratio to distinguish the controls and AD (Fig. 4d), ROC analyses revealed a very high AUC (0.90, P < 0.001; Fig. 4f), which was the same as the AUC calculated from Dataset 2.